The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
New insights into cystic fibrosis-related diabetes in children
Abstract
Cystic fibrosis-related diabetes (CFRD) is the most common complication of cystic fibrosis. It is associated with significantly increased morbidity and mortality in adults and children. Adolescents with cystic fibrosis have a much higher prevalence of diabetes than any other similar age population. Glucose abnormalities that precede diabetes are even more common, especially in children younger than 10 years. The pathophysiology of glucose metabolic abnormalities is poorly understood, but insulin insufficiency is clearly the main component. Findings from animal studies have provided insight into the pathophysiology of CFRD, and imply that carbohydrate metabolic abnormalities might begin at much younger ages than was previously thought in patients with cystic fibrosis, and might be related to the basic cystic fibrosis chloride channel defect. In this Review we explore present knowledge of CFRD in children and adolescents, and new data that indicate that the pathophysiology of CFRD begins in very young patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CGM or HOMA of b -cell function (133) may be more sensitive than OGTT to detect risk for progression to CFRD; however, evidence linking these results to long-term outcomes is lacking, and these tests are not recommended for screening outside the research setting (134).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [134]
Citations
Cites
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes
Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., Onady, G., Robinson, K. A., Sabadosa, K. A., Stecenko, A., Slovis, B., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1768 · Cited by 726
Self-citationCystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
Moran, A., Dunitz, J., Nathan, B., Saeed, A., Holme, B., & Thomas, W. (2009) · Diabetes Care · doi:10.2337/dc09-0586 · Cited by 648
Self-citationEpidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related Diabetes
Moran, A., Becker, D., Casella, S. J., Gottlieb, P. A., Kirkman, M. S., Marshall, B. C., Slovis, B., & the CFRD Consensus Conference Committee (2010) · Diabetes Care · doi:10.2337/dc10-1279 · Cited by 258
Self-citationInsulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia
Moran, A., Pekow, P., Grover, P., Zorn, M., Slovis, B., Pilewski, J., Tullis, E., Liou, T. G., Allen, H., & the Cystic Fibrosis Related Diabetes Therapy Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0585 · Cited by 240
Self-citationKoch, C., Rainisio, M., Madessani, U., Harms, H. K., Hodson, M. E., Mastella, G., McKenzie, S. G., Navarro, J., & Strandvik, B. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1142 · Cited by 218
Milla, C. E., Billings, J., & Moran, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2141 · Cited by 210
Self-citationMicrovascular Complications in Cystic Fibrosis–Related Diabetes
Schwarzenberg, S. J., Thomas, W., Olsen, T. W., Grover, T., Walk, D., Milla, C., & Moran, A. (2007) · Diabetes Care · doi:10.2337/dc06-1576 · Cited by 199
Self-citationBellin, M. D., Laguna, T., Leschyshyn, J., Regelmann, W., Dunitz, J., Billings, J., & Moran, A. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12026 · Cited by 193
Self-citationEarly Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
Hameed, S., Morton, J. R., Jaffé, A., Field, P. I., Belessis, Y., Yoong, T., Katz, T., & Verge, C. F. (2010) · Diabetes Care · doi:10.2337/dc09-1492 · Cited by 173
Research works printed but not linked: 1
- Moran, 2010, Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, 33, 2697, 10.2337/dc10-1768 · DOI · Paper page
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
“Continuous glucose monitoring or HOMA of b-cell function (79)maybemore sensitive thanOGTT to detect risk for progression to CFRD; however, evidence linking these results to long-term outcomes is lacking, and these tests are not recommended for screening (80).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Ode, K. L., & Moran, A.
- Affiliations
- University of Iowa (US)
- University of Minnesota (US)
- Corresponding author
- Ode, Katie L
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 1
- Issue
- 1
- Pages
- 52-58
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W2142006298
- Cited by
- 76
- References
- 66
- Citations by year
- 2026: 5 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 11 · 2018: 4 · 2017: 11 · 2016: 11 · 2015: 4 · 2014: 7
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R24DK096518, P30DK054759, T32DK065519)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- cystic fibrosis-related diabetes, cystic fibrosis, children, adolescents, glucose metabolism, insulin deficiency, pathophysiology, animal models
- MeSH terms
- Blood Glucose, Child, Cystic Fibrosis, Diabetes Mellitus, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New insights into cystic fibrosis-related diabetes in children. https://app.cochat.ai/papers/10.1016/s2213-8587(13)70015-9
- The paper
- Ode, K. L., & Moran, A. (2013). New insights into cystic fibrosis-related diabetes in children. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(13)70015-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.